138 related articles for article (PubMed ID: 38803279)
1. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
[TBL] [Abstract][Full Text] [Related]
2. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
3. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
[TBL] [Abstract][Full Text] [Related]
4. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Allegaert K; Flint R; Smits A
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
[No Abstract] [Full Text] [Related]
6. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
[TBL] [Abstract][Full Text] [Related]
8. Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates.
Alrahahleh D; Thoma Y; Van Daele R; Nguyen T; Halena S; Luig M; Stocker S; Kim HY; Alffenaar JW
Clin Pharmacokinet; 2024 Mar; 63(3):367-380. PubMed ID: 38416322
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
[TBL] [Abstract][Full Text] [Related]
11. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.
Germovsek E; Osborne L; Gunaratnam F; Lounis SA; Busquets FB; Standing JF; Sinha AK
J Antimicrob Chemother; 2019 Apr; 74(4):1003-1011. PubMed ID: 30668696
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
[TBL] [Abstract][Full Text] [Related]
14. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
[TBL] [Abstract][Full Text] [Related]
16. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
Brown DL; Lalla CD; Masselink AJ
Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis.
Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J
Clin Pharmacol Ther; 2021 Jan; 109(1):212-221. PubMed ID: 33190285
[TBL] [Abstract][Full Text] [Related]
19. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.
Wong S; Selby PR; Reuter SE
Pharmacol Res Perspect; 2024 Aug; 12(4):e1231. PubMed ID: 38940223
[TBL] [Abstract][Full Text] [Related]
20. Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: A simulation study.
Oda K; Yamada T; Matsumoto K; Hanai Y; Ueda T; Samura M; Shigemi A; Jono H; Saito H; Kimura T
Clin Transl Sci; 2023 Nov; 16(11):2265-2275. PubMed ID: 37718491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
